Conference abstract · 26 Apr 2018
Conference abstractPublished 19 Oct 2016
Brexit and biosimilars
PJI Biotech, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The UK decided to leave the European Union on 23 June 2016, but will Brexit change biosimilar market? One group believes that Brexit UK will have a significant impact on biosimilar market in UK because UK currently doesnâÂ?Â?t have a regulatory pathway to approve biosimilars. The approval process for biosimilars is currently carried out through a centralized procedure with the EMA. Additionally, none of the seven biosimilars available in UK are manufactured locally. Brexit could result in disruption of supply chain, additional importation testing, additional recertification requirements after importing, new import/ export charges and uncertainty regarding regulatory strategy. Others optimistic group pinpoints that the EMA is currently headquartered in London and relocation of the headquarters to other EU country will not happen soon. Furthermore, UK may not want drug manufacturers to follow two separate regulatory pathways for biosimilars. It is beneficial for both UK and EU to remain part of same regulatory scheme. How Brexit will impact regulatory pathway and approval of biosimilars, is yet to be determined. In this presentation, author will present the impact of Brexit on Biosimilar market.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
The consequences and possible consequences of brexit on biosimilars medicines
Conference abstract · 15 May 2017
Consequences of Brexit on biosimilars
Conference abstract · 19 Oct 2016
Brexit and Biosimilars
Research article · 26 Mar 2024
UK Employment and Industrial Strategy Influence on Brexit
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Dipti Gulati”

